Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or returning to patients, according to a new study. Published in the New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback